Mayumi Nishimura Selected Research

Interleukin-9 Receptors (Interleukin 9 Receptor)

8/2012	Interleukin-9 receptor gene is transcriptionally regulated by nucleolin in T-cell lymphoma cells.
11/2008	Aberrant activation of interleukin-9 receptor and downstream Stat3/5 in primary T-cell lymphomas in vivo in susceptible B6 and resistant C3H mice.
1/2004	Elevated interleukin-9 receptor expression and response to interleukins-9 and -7 in thymocytes during radiation-induced T-cell lymphomagenesis in B6C3F1 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mayumi Nishimura Research Topics

Disease

34	Neoplasms (Cancer) 03/2022 - 10/2003
18	Carcinogenesis 01/2021 - 11/2004
16	Carcinoma (Carcinomatosis) 01/2021 - 04/2006
12	Breast Neoplasms (Breast Cancer) 03/2019 - 05/2006
9	Lymphoma (Lymphomas) 01/2019 - 10/2003
8	T-Cell Lymphoma (Lymphoma, T Cell) 09/2015 - 03/2002
3	Body Weight (Weight, Body) 03/2022 - 03/2013
3	Second Primary Neoplasms (Neoplasms, Second) 10/2019 - 04/2011
3	Colonic Neoplasms (Colon Cancer) 03/2015 - 01/2006
2	Dementia (Dementias) 06/2022 - 01/2020
2	Colitis 03/2015 - 01/2006
1	Necrosis 01/2019
1	Adenocarcinoma of Lung 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Obesity 01/2016
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2015
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2015
1	Colitis-Associated Neoplasms 03/2015
1	Adenocarcinoma 03/2013
1	Adenoma (Adenomas) 03/2013
1	Radiation-Induced Neoplasms (Neoplasms, Radiation Induced) 02/2013
1	Leukemia 08/2012

Drug/Important Bio-Agent (IBA)

12	CarcinogensIBA 01/2021 - 06/2005
10	Proteins (Proteins, Gene)FDA Link 03/2017 - 06/2005
9	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2002
7	CarbonIBA 10/2019 - 10/2003
5	IonsIBA 10/2019 - 10/2003
5	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2013 - 05/2005
4	Hormones (Hormone)IBA 01/2021 - 07/2011
3	LeptinIBA 03/2022 - 01/2016
3	CytokinesIBA 01/2019 - 01/2004
3	Interleukin-9 Receptors (Interleukin 9 Receptor)IBA 08/2012 - 01/2004
2	Insulin (Novolin)FDA Link 03/2022 - 01/2016
2	Phenobarbital (Luminal)FDA Link 01/2021 - 03/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 08/2010
2	Estrogen ReceptorsIBA 01/2018 - 07/2011
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 07/2011
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2015 - 01/2006
2	Drinking WaterIBA 03/2015 - 01/2006
2	Dextrans (Dextran)FDA Link 03/2015 - 01/2006
2	Dihydrotachysterol (AT 10)IBA 03/2015 - 01/2006
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 04/2014 - 11/2011
2	Protein Isoforms (Isoforms)IBA 11/2011 - 03/2002
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2011 - 04/2006
2	beta CateninIBA 02/2006 - 01/2006
2	Codon (Codons)IBA 06/2005 - 03/2002
1	CholesterolIBA 03/2022
1	Triglycerides (Triacylglycerol)IBA 03/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	PlasticsIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2018
1	Polycomb Repressive Complex 2IBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	Biological ProductsIBA 10/2017
1	ReninIBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	Angiotensin Receptor AntagonistsIBA 01/2016
1	AngiotensinsIBA 01/2016
1	candesartanIBA 01/2016
1	Angiotensin IIIBA 01/2016
1	Losartan (Cozaar)FDA LinkGeneric 01/2016
1	CateninsIBA 03/2015
1	MutL Protein Homolog 1IBA 03/2015
1	dactolisibIBA 08/2014
1	Small Interfering RNA (siRNA)IBA 05/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	Cisplatin (Platino)FDA LinkGeneric 01/2014
1	Drug CombinationsIBA 01/2014
1	UraniumIBA 07/2013
1	uranyl acetateIBA 07/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2013
1	diisopropanolnitrosamineIBA 03/2013
1	AminesIBA 03/2013
1	Surface-Active Agents (Surfactants)IBA 03/2013
1	Apoprotein(a) (Apolipoprotein (a))IBA 03/2013
1	MicroRNAs (MicroRNA)IBA 02/2013
1	RNA (Ribonucleic Acid)IBA 02/2013
1	A-Form DNA (A-DNA)IBA 01/2013
1	NucleolinIBA 08/2012
1	Interleukin-9 (Interleukin 9)IBA 08/2012
1	Sirolimus (Rapamycin)FDA Link 11/2011
1	benzocycloheptapyridineIBA 11/2011
1	TOR Serine-Threonine KinasesIBA 11/2011
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2011
1	Therapeutic UsesIBA 11/2011
1	LigandsIBA 07/2011
1	ErbB Receptors (EGF Receptor)IBA 07/2011

Therapy/Procedure

7	Radiotherapy 03/2022 - 04/2006
2	Aftercare (After-Treatment) 01/2021 - 03/2013
2	Drug Therapy (Chemotherapy) 08/2014 - 01/2014
1	Palliative Care (Palliative Therapy) 06/2022
1	Nuclear Power Plants 01/2021
1	Terminal Care (Care, Terminal) 01/2020
1	Heavy Ion Radiotherapy 01/2015
1	Therapeutics 03/2013